We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Enlivex Therapeutics

News List

Israeli Ministry of Health Authorizes Trial Evaluating Allocetra in Sepsis Patients americanpharmaceuticalreview
November 12, 2020
Enlivex Therapeutics reported the Israeli Ministry of Health authorized the initiation of a proposed Company-sponsored Phase IIb clinical trial evaluating Allocetra™, in sepsis patients.
Israeli Ministry of Health Authorizes Trial Initiation Evaluating Allocetra for COVID-19 americanpharmaceuticalreview
October 21, 2020
Enlivex Therapeutics reported that the Israeli Ministry of Health authorized the initiation of a proposed investigator-initiated Phase II clinical trial evaluating Allocetra in severe and critical COVID-19 patients.
Enlivex Announces Trial Initiation of Allocetra in COVID-19 Patients americanpharmaceuticalreview
May 12, 2020
Enlivex Therapeutics announced an investigator-initiated multi-center Phase II clinical trial of Allocetra in COVID-19 patients has commenced.
Enlivex Announces Positive Final Safety and Efficacy Data from Allocetra Study americanpharmaceuticalreview
March 20, 2020
Enlivex Therapeutics announced positive final safety and efficacy data from the Company’s completed Phase Ib clinical trial in patients with severe sepsis.